Physician
KD Medical Group,inc.
KD Medical Group,inc. was paid $4.33M by Medicaid between Jan 2018 and Dec 2024, across 152 billing codes. Its largest line is 0241U, Neonatal screening for hereditary disorders, genomic sequence analysis panel — 27% of everything it billed.
33Billing provider infoKD MEDICAL GROUP,INC.
LOS BANOS, CA 93635
LOS BANOS, CA 93635
33aNPI1457522567assigned 03/17/2008
33bProvider typeInternal Medicine Physician
28Total paid$4.33M
24GClaims140,918
24DCodes billed152
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#35 of 2,679
Median peer was paid$13K
This provider vs. median344×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,931 | $507K | |
| 2019 | 11,461 | $406K | |
| 2020 | 12,271 | $320K | |
| 2021 | 22,736 | $575K | |
| 2022 | 26,157 | $874K | |
| 2023 | 30,465 | $910K | |
| 2024incomplete | 26,897 | $740K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 27% | 9,220 | 8,745 | $1.18M |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 14% | 1,823 | 1,428 | $615K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4.8% | 1,905 | 1,904 | $206K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.7% | 950 | 950 | $161K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.5% | 1,939 | 1,924 | $150K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.7% | 1,834 | 1,794 | $119K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.7% | 5,445 | 5,398 | $119K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 8,718 | 8,580 | $118K |
| 80061 | Lipid panel | 2.2% | 9,103 | 9,019 | $96K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.1% | 4,937 | 4,229 | $90K |
| 86769 | 2.0% | 1,361 | 1,334 | $88K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 2,764 | 2,731 | $87K |
140 more codes
| 80053 | Comprehensive metabolic panel | 1.9% | 9,492 | $81K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.6% | 1,753 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 10,355 | $64K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.3% | 5,811 | $57K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 504 | $54K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 6,369 | $52K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 1,602 | $52K |
| 84439 | 1.1% | 6,392 | $46K | |
| 0012A | <1% | 1,101 | $39K | |
| 73562 | <1% | 1,129 | $38K | |
| 0011A | <1% | 1,086 | $35K | |
| 76536 | <1% | 333 | $33K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 890 | $32K |
| 0001A | <1% | 708 | $27K | |
| 72100 | <1% | 833 | $26K | |
| 82746 | <1% | 2,128 | $26K | |
| 90715 | <1% | 592 | $25K | |
| 73630 | <1% | 856 | $25K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 235 | $24K |
| 0002A | <1% | 598 | $24K | |
| 11721 | <1% | 3,978 | $21K | |
| 86480 | <1% | 458 | $20K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 101 | $19K |
| 76770 | <1% | 194 | $18K | |
| 82607 | <1% | 1,516 | $18K | |
| 99460 | <1% | 192 | $17K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 660 | $17K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 356 | $17K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 156 | $16K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 139 | $16K |
| 86481 | <1% | 253 | $16K | |
| 76641 | <1% | 117 | $14K | |
| 84480 | <1% | 1,191 | $13K | |
| 73030 | <1% | 512 | $13K | |
| 72110 | <1% | 300 | $12K | |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 209 | $12K |
| 99490 | Ccm add 20min | <1% | 3,911 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 398 | $10K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,184 | $10K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,202 | $9K |
| 11056 | <1% | 927 | $8K | |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 176 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 181 | $8K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 45 | $8K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 39 | $7K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,714 | $7K |
| 99462 | <1% | 175 | $7K | |
| 83550 | <1% | 956 | $6K | |
| 83540 | <1% | 1,149 | $6K | |
| 72040 | <1% | 200 | $6K | |
| 73610 | <1% | 162 | $5K | |
| 81002 | <1% | 2,932 | $5K | |
| 90686 | <1% | 179 | $5K | |
| 99454 | <1% | 710 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 772 | $4K |
| 81025 | <1% | 1,266 | $4K | |
| 74018 | <1% | 102 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 206 | $4K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 55 | $3K |
| 0013A | <1% | 78 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 431 | $3K |
| 84153 | <1% | 175 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 25 | $2K |
| 80305 | <1% | 242 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 88 | $2K |
| 20611 | <1% | 52 | $2K | |
| 82977 | <1% | 429 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 44 | $2K |
| 95144 | <1% | 79 | $2K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 469 | $2K |
| 82728 | <1% | 185 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $2K |
| 73130 | <1% | 57 | $2K | |
| 80076 | <1% | 279 | $2K | |
| 86140 | <1% | 395 | $2K | |
| 99000 | <1% | 438 | $2K | |
| 92250 | <1% | 67 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 16 | $2K |
| 69209 | <1% | 187 | $1K | |
| 76642 | <1% | 14 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 15 | $1K |
| 86235 | <1% | 14 | $1K | |
| 90673 | <1% | 14 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 129 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 41 | $1K |
| 90682 | <1% | 13 | $1K | |
| 86580 | <1% | 283 | $963.83 | |
| 72050 | <1% | 25 | $917.32 | |
| 82962 | <1% | 415 | $838.44 | |
| 83735 | <1% | 159 | $830.07 | |
| A6219 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 64 | $682.40 |
| 90656 | <1% | 24 | $643.44 | |
| 82044 | <1% | 157 | $598.46 | |
| 0031A | <1% | 20 | $591.29 | |
| 77085 | <1% | 13 | $564.80 | |
| 73110 | <1% | 14 | $533.04 | |
| 99457 | <1% | 229 | $518.16 | |
| A6266 | Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard | <1% | 57 | $517.05 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 47 | $456.56 |
| 84550 | <1% | 179 | $448.13 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 65 | $414.00 |
| 85652 | <1% | 190 | $405.57 | |
| 93922 | <1% | 12 | $353.28 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 493 | $342.30 |
| 90648 | <1% | 26 | $234.00 | |
| 90670 | <1% | 26 | $234.00 | |
| 90723 | <1% | 21 | $189.00 | |
| 99335 | <1% | 872 | $157.27 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 35 | $148.94 |
| 86225 | <1% | 14 | $146.91 | |
| 90680 | <1% | 16 | $144.00 | |
| 99458 | <1% | 103 | $137.19 | |
| A6453 | Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard | <1% | 63 | $134.21 |
| 86226 | <1% | 14 | $129.54 | |
| 83516 | <1% | 15 | $118.99 | |
| 99453 | <1% | 40 | $117.60 | |
| 85018 | <1% | 46 | $101.98 | |
| 86200 | <1% | 14 | $85.42 | |
| 86430 | <1% | 14 | $60.64 | |
| 86431 | <1% | 14 | $60.44 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 99 | $46.21 |
| 99173 | <1% | 13 | $40.56 | |
| 90688 | <1% | 16 | $31.22 | |
| 82150 | <1% | 13 | $16.36 | |
| 84450 | <1% | 19 | $12.60 | |
| 82947 | <1% | 18 | $10.11 | |
| 99318 | <1% | 13 | $9.94 | |
| 84460 | <1% | 18 | $9.34 | |
| 82565 | <1% | 18 | $8.80 | |
| 84075 | <1% | 18 | $8.42 | |
| 82310 | <1% | 18 | $8.36 | |
| 82247 | <1% | 18 | $8.34 | |
| 82040 | <1% | 18 | $8.20 | |
| 84520 | <1% | 18 | $6.42 | |
| 84155 | <1% | 18 | $6.04 | |
| 3078F | 0% | 15 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 23 | $0.00 |
| 99327 | 0% | 13 | $0.00 | |
| 3074F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEVIREDDY, KARTHIKEYA (MEDICAL DIRECTOR)
Parent organizationKD MEDICAL GROUP,INC.
| Provider | Location | Paid |
|---|---|---|
| Karthikeya Devireddy MD INC | Los Banos, CA | $22.58M |
| Dos Palos Apex Health Center INC | Dos Palos, CA | $2.21M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.